The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from Photonics RSS Feed.
Bruker Corp. has acquired Canopy Biosciences, a specialist in high multiplex biomarker imaging for immunology, immune-oncology, and cell therapy. The acquisition expands Bruker’s offerings in targeted multiomics and fluorescence-based imaging techniques. Financial details of the transaction have not been disclosed.
Bruker also recently announced the appointment of Bonnie H. Anderson to its board of directors.READ MORE